サンプル依頼リスト カート
  • English
表紙：アトピー性皮膚炎治療市場規模、シェア、成長分析、治療タイプ別、年齢層別、重症度別、地域別 - 産業予測、2025年～2032年
市場調査レポート
商品コード
1789233

アトピー性皮膚炎治療市場規模、シェア、成長分析、治療タイプ別、年齢層別、重症度別、地域別 - 産業予測、2025年～2032年

Atopic Dermatitis Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Topical Treatments, Systemic Treatments), By Age Group (Pediatric, Adult and Geriatric), By Severity, By Region - Industry Forecast 2025-2032

出版日
発行
SkyQuest
ページ情報
英文 186 Pages
納期
3～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
アトピー性皮膚炎治療市場規模、シェア、成長分析、治療タイプ別、年齢層別、重症度別、地域別 - 産業予測、2025年～2032年
出版日: 2025年08月07日
発行: SkyQuest
ページ情報: 英文 186 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

アトピー性皮膚炎治療の世界市場規模は2023年に172億米ドルと評価され、2024年には186億米ドル、2032年には352億米ドルに成長し、予測期間（2025-2032年）のCAGRは8.3％で成長する見込みです。

アトピー性皮膚炎治療の世界市場は、罹患率の上昇と早期診断につながる患者意識の高まりにより、大きな成長を遂げています。このような需要の急増は、標的生物製剤や免疫経路を正確に調節する低分子阻害剤などの治療法の進歩につながっています。従来の注射薬に課題する経口薬などの革新的治療により、患者の選択肢は多様化しています。処方箋による治療とデジタルヘルスソリューションを組み合わせた、個別化された治療計画や統合医療を目指す傾向が顕著です。バイオテクノロジー企業は、多様な患者のニーズに応えるため、選択的ヤヌスキナーゼ阻害剤や次世代生物製剤の開発に注力しています。さらに、主要企業間の戦略的買収がイノベーションを強化する一方、遠隔皮膚科サービスの拡大やリアルワールドエビデンスへの取り組みが患者のモニタリングと臨床的意思決定を改善しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数（2024年）
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • ケーススタディ
  • 顧客購買行動分析

アトピー性皮膚炎治療市場規模：治療タイプ別& CAGR（2025-2032）

  • 市場概要
  • 局所治療
  • 全身治療
  • 光線療法
  • 生物学的製剤

アトピー性皮膚炎治療市場規模：年齢層別& CAGR（2025-2032）

  • 市場概要
  • 小児
  • 成人
  • 高齢者

アトピー性皮膚炎治療市場規模：重症度別& CAGR（2025-2032）

  • 市場概要
  • 軽度
  • 中程度
  • 重度

アトピー性皮膚炎治療市場規模：地域別& CAGR（2025-2032）

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング（2024年）
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析（2024年）
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較（2022-2024年）

主要企業プロファイル

  • AbbVie（USA）
  • Sanofi（France）
  • Regeneron（USA）
  • Novartis（Switzerland）
  • Pfizer（USA）
  • LEO Pharma（Denmark）
  • Johnson & Johnson（USA）
  • Eli Lilly（USA）
  • Boehringer Ingelheim（Germany）
  • GSK（UK）
  • Innovaderm Research（Canada）
  • Arcutis Biotherapeutics（USA）
  • Kyowa Kirin（Japan）

結論と提言

目次
Product Code: SQMIG35I2428

Global Atopic Dermatitis Treatment Market Size was valued at USD 17.2 Billion in 2023 poised to grow between USD 18.6 Billion in 2024 to USD 35.2 Billion by 2032, growing at a CAGR of 8.3% in the forecast period (2025-2032).

The global atopic dermatitis treatment market is experiencing significant growth due to the rising incidence of the condition and increasing patient awareness leading to early diagnoses. This surge in demand has led to advancements in therapies, including targeted biologics and small-molecule inhibitors that precisely modulate immune pathways. Innovative treatments, such as oral medications that challenge traditional injectables, are diversifying patient options. There is a notable trend towards personalized treatment plans and integrated care, combining prescription therapies with digital health solutions. Biotech companies are focused on developing selective Janus kinase inhibitors and next-generation biologics to meet varied patient needs. Additionally, strategic acquisitions among key players are enhancing innovation, while expanding teledermatology services and real-world evidence initiatives are improving patient monitoring and clinical decision-making.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Atopic Dermatitis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Atopic Dermatitis Treatment Market Segments Analysis

The global atopic dermatitis treatment market is segmented based on treatment type, age group, severity, and region. In terms of treatment type, the market is divided into topical treatments, systemic treatments, phototherapy, and biologics. Based on age group, the market is trifurcated into pediatric, adult and geriatric. Based on severity, the market is grouped into mild, moderate, and severe. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America and the Middle East & Africa.

Driver of the Global Atopic Dermatitis Treatment Market

The increasing accessibility of biologic therapies that specifically target immune pathways has transformed the management of moderate to severe atopic dermatitis. These innovative treatments effectively decrease the frequency and severity of flare-ups by regulating interleukin activity and other inflammatory responses. With their extended duration of effectiveness and minimized systemic side effects, they enhance disease control, leading to improved patient outcomes. This, in turn, encourages wider adoption of these therapies in various clinical environments, driving significant growth in the global atopic dermatitis treatment market. The positive impact of these advancements is pivotal for patients seeking effective long-term relief from this chronic condition.

Restraints in the Global Atopic Dermatitis Treatment Market

The Global Atopic Dermatitis Treatment market faces significant challenges due to the high costs associated with advanced therapies, which render them inaccessible for many patients. Even in well-resourced healthcare systems, payers frequently restrict coverage to only severe cases, creating additional hurdles for those in need. These financial barriers can impede the start of necessary treatments, lead to delays in therapy initiation, and ultimately slow down the overall development of the treatment market in both established and emerging economies. As a result, the potential for effective care remains limited, impacting patient outcomes and satisfaction.

Market Trends of the Global Atopic Dermatitis Treatment Market

The Global Atopic Dermatitis Treatment market is witnessing a notable shift towards precision immunotherapies, tailoring treatment pathways to target specific inflammatory mechanisms. This evolution includes the advancement of biologics that inhibit inflammatory interleukins and the emerging small molecule JAK inhibitors, which are transitioning from clinical trials to real-world applications. Such innovations enhance the clinician's ability to personalize therapies, aligning them with individual patient profiles and varying degrees of disease severity. As healthcare providers increasingly adopt these targeted approaches, the market is expected to grow significantly, driven by the demand for more effective, individualized treatment options in managing atopic dermatitis.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Atopic Dermatitis Treatment Market Size by Treatment Type & CAGR (2025-2032)

  • Market Overview
  • Topical Treatments
  • Systemic Treatments
  • Phototherapy
  • Biologics

Global Atopic Dermatitis Treatment Market Size by Age Group & CAGR (2025-2032)

  • Market Overview
  • Pediatric
  • Adult
  • Geriatric

Global Atopic Dermatitis Treatment Market Size by Severity & CAGR (2025-2032)

  • Market Overview
  • Mild
  • Moderate
  • Severe

Global Atopic Dermatitis Treatment Market Size & CAGR (2025-2032)

  • North America (Treatment Type, Age Group, Severity)
    • US
    • Canada
  • Europe (Treatment Type, Age Group, Severity)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Treatment Type, Age Group, Severity)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Treatment Type, Age Group, Severity)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Treatment Type, Age Group, Severity)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • AbbVie (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Regeneron (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LEO Pharma (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GSK (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Innovaderm Research (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arcutis Biotherapeutics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kyowa Kirin (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations